William L. Macias, Chief Medical Officer at Immunovant, Inc. (IMVT), sold 2,055 shares at $20.86 ($43K) on 2025-02-19, disclosed to the SEC on 2025-02-21.
Open-market sale of $43k IMVT by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| IMVT | SELL | 2024-10-18 | $167K | — | Filing → |
| IMVT | SELL | 2024-08-23 | $189K | — | Filing → |
| IMVT | SELL | 2024-07-19 | $160K | — | Filing → |